Peripheral Blood Platelet-Lymphocyte Ratio Is Good Predictor of Chemosensitivity and Prognosis in Gastric Cancer Patients (Q89939879)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32110104 AND SRC:MED&resulttype=core&format=json

9 April 2020

title

Peripheral Blood Platelet-Lymphocyte Ratio Is Good Predictor of Chemosensitivity and Prognosis in Gastric Cancer Patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32110104 AND SRC:MED&resulttype=core&format=json

9 April 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32110104 AND SRC:MED&resulttype=core&format=json

9 April 2020

Hiroto Saito

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32110104 AND SRC:MED&resulttype=core&format=json

9 April 2020

Hidehiro Tajima

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32110104 AND SRC:MED&resulttype=core&format=json

9 April 2020

Itasu Ninomiya

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32110104 AND SRC:MED&resulttype=core&format=json

9 April 2020

author name string

Yuka Ohe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32110104 AND SRC:MED&resulttype=core&format=json

9 April 2020

Takahisa Yamaguchi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32110104 AND SRC:MED&resulttype=core&format=json

9 April 2020

Jun Kinoshita

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32110104 AND SRC:MED&resulttype=core&format=json

9 April 2020

Koichi Okamoto

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32110104 AND SRC:MED&resulttype=core&format=json

9 April 2020

Keishi Nakamura

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32110104 AND SRC:MED&resulttype=core&format=json

9 April 2020

Tetsuo Ohta

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32110104 AND SRC:MED&resulttype=core&format=json

9 April 2020

publication date

20 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32110104 AND SRC:MED&resulttype=core&format=json

Cancer Management and Research

9 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32110104 AND SRC:MED&resulttype=core&format=json

9 April 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32110104 AND SRC:MED&resulttype=core&format=json

9 April 2020

page(s)

1303-1311

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32110104 AND SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial 3.0 Unported

9 April 2020

copyright license

start time

1 February 2020

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

A comparison of multimodality treatment: two or four courses of paclitaxel plus cisplatin or S-1 plus cisplatin followed by surgery for locally advanced gastric cancer, a randomized Phase II trial (COMPASS).

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: a retrospective observational study

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Metastasis-promoting role of extravasated platelet activation in tumor

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Platelets surrounding primary tumor cells are related to chemoresistance

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Impact of Extravasated Platelet Activation and Podoplanin-positive Cancer-associated Fibroblasts in Pancreatic Cancer Stroma

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Clinical significance of pre-operative neutrophil lymphocyte ratio and platelet lymphocyte ratio as prognostic factors for patients with colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Prognostic nutritional index as a predictor of survival in resectable gastric cancer patients with normal preoperative serum carcinoembryonic antigen levels: a propensity score matching analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Predictive Value of Neutrophil/Lymphocyte Ratio for Efficacy of Preoperative Chemotherapy in Triple-Negative Breast Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Peripheral inflammation/immune indicators of chemosensitivity and prognosis in breast cancer patients treated with neoadjuvant chemotherapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Japanese classification of gastric carcinoma: 3rd English edition

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Feasibility and efficacy of preoperative chemotherapy with docetaxel, cisplatin and S-1 in gastric cancer patients with para-aortic lymph node metastases.

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Efficacy of pre‐operative chemotherapy with docetaxel, cisplatin, and S‐1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para‐aortic lymph nodes

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

A multicenter, phase I dose-escalating study of docetaxel, cisplatin and S-1 for advanced gastric cancer (KDOG0601).

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Immunity, Inflammation, and Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Hallmarks of Cancer: The Next Generation

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Towards understanding the role of cancer-associated inflammation in chemoresistance

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

TGF-beta-induced epithelial to mesenchymal transition

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Regulatory T cells in tumor immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development.

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Barriers to drug delivery in solid tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Targeting VEGF/VEGFR to Modulate Antitumor Immunity.

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Immunophenotyping of patients with oral squamous cell carcinoma in peripheral blood and associated tumor tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Oncology meets immunology: the cancer-immunity cycle

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Immunogenic cell death in cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

A prospective multi-institutional validity study to evaluate the accuracy of clinical diagnosis of pathological stage III gastric cancer (JCOG1302A).

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

The impact of preoperative lymph node size on long-term outcome following curative gastrectomy for gastric cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Validity of response assessment criteria in neoadjuvant chemotherapy for gastric cancer (JCOG0507-A).

31 March 2020

1 reference

https://api.crossref.org/works/10.2147/CMAR.S241069

Five-year cancer cure: relation to total amount of peripheral lymphocytes and neutrophils

31 March 2020

1 reference

12 December 2020

Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance

1 reference

12 December 2020

Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer.

1 reference

12 December 2020

Evidence for acute vascular toxicity of cisplatin-based chemotherapy in patients with germ cell tumour

1 reference

12 December 2020

Identifiers

DOI

10.2147/CMAR.S241069

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32110104 AND SRC:MED&resulttype=core&format=json

9 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32110104 AND SRC:MED&resulttype=core&format=json

9 April 2020

PubMed publication ID

32110104

1 reference